• 2009 July 01

Company Description

Non-Invasive Prenatal Diagnostics

Start-up company developing innovative front-line prenatal genetic diagnostic methods, based on Next Generation Sequencing (NGS) technologies. Our product is based on molecular diagnostic method that identifies fetal chromosomal abrasions (and specifically Down-syndrome) by noninvasive procedures, use of maternal blood from an early pregnancy stage.